EFFECT OF THE AGONIST OF PPAR-y, ROSIGLITAZONE, ON LIPID PROFILE AND GLUCOSE TOLERANCE IN BRAZILIAN OBESE SUBJECTS.
Autor: | Barroso, S G, Genelhu-Fagundes, V, Duarte, S FP, Rodrigues, M LG, Valença, D CT, Sanjuliani, A F, Pimentel, M MG, Francischetti, E A |
---|---|
Zdroj: | Journal of Hypertension; 2004 Supplement 1, Vol. 22, pS101-S101, 1p |
Databáze: | Complementary Index |
Externí odkaz: |